What is Adapttech?
Adapttech operates at the intersection of biomedical engineering and assistive technology, focusing on the development of sophisticated tools designed to empower healthcare professionals. The company's core value proposition lies in its ability to provide actionable data that improves the quality of life for individuals with physical limitations. By integrating sensor-based hardware with intuitive software interfaces, Adapttech enables clinicians to optimize prosthetic fittings and rehabilitation protocols with unprecedented precision. This market position is bolstered by a commitment to evidence-based innovation, allowing the firm to address critical inefficiencies in traditional physical therapy and mobility support systems.
How much funding has Adapttech raised?
Adapttech has raised a total of $6.6M across 3 funding rounds:
Other Financing Round
$915K
Other Financing Round
$2.8M
Unspecified
$2.9M
Other Financing Round (2018): $915K, investors not publicly disclosed
Other Financing Round (2021): $2.8M led by wren capital, Bionova Capital, Midlands Engine, ACF Investors, and Wealth Club
Unspecified (2022): $2.9M supported by MEIF Proof of Concept & Early Stage Fund, Wealth Club, and EIS funds
Key Investors in Adapttech
Wren Capital
Wren Capital is an angel investment firm specializing in science, engineering, and software, with a particular focus on medical devices and technical innovation.
Bionova Capital
Bionova Capital is a venture firm dedicated to supporting early-stage life sciences and biomedical companies through strategic financial and operational guidance.
Wealth Club
Wealth Club is a prominent investment platform that provides high-net-worth individuals access to private equity and venture capital opportunities in growing sectors.
What's next for Adapttech?
With the recent influx of capital, Adapttech is strategically positioned to transition from early-stage development to a mature enterprise-level entity. The roadmap ahead likely involves the expansion of its commercial distribution channels and the deepening of its R&D pipeline to include next-generation diagnostic capabilities. As the company scales, it will focus on strengthening its regulatory compliance frameworks and fostering strategic partnerships with major healthcare networks. This phase of growth is critical for establishing long-term market dominance, as the firm seeks to standardize its technology as a benchmark for patient care in the global rehabilitation market.
See full Adapttech company page
